DVAX

NASDAQ:DVAX

Dynavax Technologies

Add to Watchlist
  • Stock

11.48

−2.30%

0.66

USD last updated 14/08 01:46:41

Last Close

10.82

13/08 20:01

Market Cap

1.39B

Beta: 1.48

Volume Today

1.51M

Avg: 1.39M

PE Ratio

26.94

PFCF: 18.82

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the ad...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    1020302018-12-312020-03-112022-02-282023-08-032024-10-24

    Revenue (Estimate*)

    50M100M150M200M250M2018-12-312020-03-112022-02-282023-08-032024-10-24

    *Estimate based on analyst consensus